L366-0307 Screening compound: 1-(4-methoxyphenyl)-3-[2-(4-methylbenzenesulfonamido)-1,3-benzothiazol-6-yl]urea

L366-0307 Screening compound: 1-(4-methoxyphenyl)-3-[2-(4-methylbenzenesulfonamido)-1,3-benzothiazol-6-yl]urea
L366-0307 Screening compound: 1-(4-methoxyphenyl)-3-[2-(4-methylbenzenesulfonamido)-1,3-benzothiazol-6-yl]urea alternative view

Chemical Structure Depiction of ChemDiv screening compound L366-0307
1-(4-methoxyphenyl)-3-[2-(4-methylbenzenesulfonamido)-1,3-benzothiazol-6-yl]urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L366-0307

Molecular Formula

C22H20N4O4S2 (C22 H20 N4 O4 S2)

Compound Name

1-(4-methoxyphenyl)-3-[2-(4-methylbenzenesulfonamido)-1,3-benzothiazol-6-yl]urea

IUPAC name

1-(4-methoxyphenyl)-3-[2-(4-methylbenzenesulfonamido)-13-benzothiazol-6-yl]urea

SMILES

Cc(cc1)ccc1S(Nc1nc(ccc(NC(Nc(cc2)ccc2OC)=O)c2)c2s1)(=O)=O

InChI

InChI=1S/C22H20N4O4S2/c1-14-3-10-18(11-4-14)32(28,29)26-22-25-19-12-7-16(13-20(19)31-22)24-21(27)23-15-5-8-17(30-2)9-6-15/h3-13H,1-2H3,(H,25,26)(H2,23,24,27)

InChI Key

IKKFELKZUOBRSL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15125273

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

468.56

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.593

Distribution Coefficient, logD

5.192

Water Solubility, LogSw

-5.43

Polar Surface Area

90.496

Acid Dissociation Constant (pKa)

7.22

Base Dissociation Constant (pKb)

0.45

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

9.10

L366-0307 in Drug Discovery

Included in Screening Libraries

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • Epigenetic
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with L366-0307 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L366-0307?
Check Price and Availability of L366-0307, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L366-0307 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L366-0307
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L366-0307
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L366-0307 available by request